Assembly Biosciences Stock Probability of Future Stock Price Finishing Over 25.39
| ASMB Stock | USD 25.39 1.66 6.14% |
Closest to current price Assembly long PUT Option Payoff at Expiration
Assembly Biosciences Target Price Odds to finish over 25.39
The tendency of Assembly Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 25.39 | 90 days | 25.39 | about 98.0 |
Based on a normal probability distribution, the odds of Assembly Biosciences to move above the current price in 90 days from now is about 98.0 (This Assembly Biosciences probability density function shows the probability of Assembly Stock to fall within a particular range of prices over 90 days) .
Assembly Biosciences Price Density |
| Price |
Predictive Modules for Assembly Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Assembly Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Assembly Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Assembly Biosciences is not an exception. The market had few large corrections towards the Assembly Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Assembly Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Assembly Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.15 | |
β | Beta against Dow Jones | 0.94 | |
σ | Overall volatility | 3.48 | |
Ir | Information ratio | -0.04 |
Assembly Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Assembly Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Assembly Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Assembly Biosciences generated a negative expected return over the last 90 days | |
| Assembly Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (40.18 M) with loss before overhead, payroll, taxes, and interest of (24.65 M). | |
| Assembly Biosciences currently holds about 116.69 M in cash with (51.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.41. | |
| Assembly Biosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from aol.com: Planned Parenthood would get 90M from state under bill |
Assembly Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Assembly Stock often depends not only on the future outlook of the current and potential Assembly Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Assembly Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6 M | |
| Cash And Short Term Investments | 112.1 M |
Assembly Biosciences Technical Analysis
Assembly Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Assembly Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Assembly Biosciences. In general, you should focus on analyzing Assembly Stock price patterns and their correlations with different microeconomic environments and drivers.
Assembly Biosciences Predictive Forecast Models
Assembly Biosciences' time-series forecasting models is one of many Assembly Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Assembly Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Assembly Biosciences
Checking the ongoing alerts about Assembly Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Assembly Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Assembly Biosciences generated a negative expected return over the last 90 days | |
| Assembly Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (40.18 M) with loss before overhead, payroll, taxes, and interest of (24.65 M). | |
| Assembly Biosciences currently holds about 116.69 M in cash with (51.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.41. | |
| Assembly Biosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from aol.com: Planned Parenthood would get 90M from state under bill |
Check out Assembly Biosciences Analysis, Assembly Biosciences Valuation, Assembly Biosciences Correlation, Assembly Biosciences Hype Analysis, Assembly Biosciences Volatility, Assembly Biosciences Price History as well as Assembly Biosciences Performance. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.60) | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.